Overview

A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain

Status:
Recruiting
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
This is a phase 3, multicenter, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of elagolix tablets versus placebo in premenopausal women with moderate or severe endometriosis-associated pain.
Phase:
Phase 3
Details
Lead Sponsor:
Nanjing Chia-tai Tianqing Pharmaceutical